Concepedia

Jeff Hsu

JH

Statistics

Publications

14

Citations

2.8K

H-Index

11

Active since

2002

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Pharmacyclics (United States)

University of California, San Francisco

Southampton General Hospital

Mary Crowley Cancer Research Center

Jeff Hsu is an author at Ionis Pharmaceuticals (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

2002–2022

14

Publications

14

The Noncoding RNA <i>MALAT1</i> Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells

Tony Gutschner, Monika Hämmerle, Jeff Hsu et al. · Cancer Research · 2012 · 1.6K citations

Medicine, Genetics, Oncology +17

AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer

David S. Hong, Razelle Kurzrock, Youngsoo Kim et al. · Science Translational Medicine · 2015 · 440 citations · Full text

Medicine, Cancer Biology, Oncology +8

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial

Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 288 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients

A. Tang, J. Knott, J. Nanson et al. · European Journal of Cardio-Thoracic Surgery · 2002 · 107 citations

Medicine, Cardiology, Perioperative Medicine +17

A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice

Minh D. To, Jesús Pérez‐Losada, Jian‐Hua Mao et al. · Nature Genetics · 2006 · 69 citations · Full text

Medicine, Genetics, Oncology +10

1–5 of 14